Next Article in Journal
Effect of a Sequential Butyrate–Probiotic Administration on Symptoms and Stool Consistency in Patients with Irritable Bowel Syndrome: A Randomized Controlled Study
Next Article in Special Issue
Elevated Plasma Adrenomedullin Levels in Patients with Unresectable Advanced Gastrointestinal Cancers
Previous Article in Journal
Systematic Review of Malignancy Risk with Biologic, Advanced Small-Molecule, and Thiopurine Therapies for Inflammatory Bowel Disease
Previous Article in Special Issue
Enteric Infections in Relapsing Ulcerative Colitis Patients in Albania: The Predictive Value of CRP/Albumin Ratio
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Gastrointestinal Disorders
Volume 8
Issue 3
10.3390/gidisord8030039
gastrointestdisord-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Brief Report

Orodispersible Budesonide Tablets in Pediatric Patients with Eosinophilic Esophagitis—A Viennese Experience

by
Rebecca Einspieler
*,
Judith Pichler
,
Wolf-Dietrich Huber
,
Andreas Heilos
,
Christoph Aufricht
and
Bettina Bidmon-Fliegenschnee
Division of Pediatric Nephrology and Gastroenterology, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, 1090 Vienna, Austria
*
Author to whom correspondence should be addressed.
Gastrointest. Disord. 2026, 8(3), 39; https://doi.org/10.3390/gidisord8030039
Submission received: 8 June 2026 / Revised: 26 July 2026 / Accepted: 27 July 2026 / Published: 31 July 2026
(This article belongs to the Special Issue Feature Papers in Gastrointestinal Disorders in 2025–2026)
Versions Notes

Abstract

Background: Orodispersible budesonide tablets (OBTs, Jorveza) are approved by the EMA as a therapy option in eosinophilic esophagitis (EoE) in adults. However, data on their use in pediatric patients remain limited and no approved pediatric OBT formulation is currently available in Europe. Therefore, real-world data on off-label use of OBTs in children is needed. Methods: We retrospectively analyzed data on the off-label use of OBTs in eight children (five girls) at a median age of 10.5 years (ranging from 5 to 14). Clinical, histological and safety outcomes were assessed descriptively. Results: Treatment with OBTs was associated with clinical improvement and a reduction in eosinophil counts. Specifically, the median eosinophil count decreased from 38.5 (ranging from 20 to 100) to 0 (ranging from 0 to 20) eosinophils per high-power field. Histological remission, defined as <15 eosinophils per high-power field, was achieved in six of eight patients (75%). Clinical remission was reached in seven of eight patients (87.5%). No severe side effects could be detected. Conclusions: OBTs showed promising clinical and histological responses in this small retrospective pediatric case series. However, larger prospective studies are required before efficacy and safety can be established. Further clinical studies are needed to assess whether OBTs could become an approved pediatric therapy.
Keywords: pediatric; eosinophilic esophagitis; therapy; budesonide pediatric; eosinophilic esophagitis; therapy; budesonide

Share and Cite

MDPI and ACS Style

Einspieler, R.; Pichler, J.; Huber, W.-D.; Heilos, A.; Aufricht, C.; Bidmon-Fliegenschnee, B. Orodispersible Budesonide Tablets in Pediatric Patients with Eosinophilic Esophagitis—A Viennese Experience. Gastrointest. Disord. 2026, 8, 39. https://doi.org/10.3390/gidisord8030039

AMA Style

Einspieler R, Pichler J, Huber W-D, Heilos A, Aufricht C, Bidmon-Fliegenschnee B. Orodispersible Budesonide Tablets in Pediatric Patients with Eosinophilic Esophagitis—A Viennese Experience. Gastrointestinal Disorders. 2026; 8(3):39. https://doi.org/10.3390/gidisord8030039

Chicago/Turabian Style

Einspieler, Rebecca, Judith Pichler, Wolf-Dietrich Huber, Andreas Heilos, Christoph Aufricht, and Bettina Bidmon-Fliegenschnee. 2026. "Orodispersible Budesonide Tablets in Pediatric Patients with Eosinophilic Esophagitis—A Viennese Experience" Gastrointestinal Disorders 8, no. 3: 39. https://doi.org/10.3390/gidisord8030039

APA Style

Einspieler, R., Pichler, J., Huber, W.-D., Heilos, A., Aufricht, C., & Bidmon-Fliegenschnee, B. (2026). Orodispersible Budesonide Tablets in Pediatric Patients with Eosinophilic Esophagitis—A Viennese Experience. Gastrointestinal Disorders, 8(3), 39. https://doi.org/10.3390/gidisord8030039

Article Metrics

Back to TopTop